Today's
Top 10 picks:-
CPHI,
TZYM, CPRX, ABIO, CRME and more
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Showing posts with label Biopharma stocks. Show all posts
Showing posts with label Biopharma stocks. Show all posts
Thursday, February 7, 2013
Thursday, January 24, 2013
Top 5 Health Care, BioPharma Stocks, BIOD, SYN, BSDM, CYTX, IDIX, CADX, 01/24/2013
Today's
Top 10 Picks: 01/24/2013
ETAK,
SCON, HNSN, CBR, PGNX
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, FREE, Sun Dried, Nutrient Rich, Piping Hot Picks Everyday!
Largest
One Day Drop, what it means for AAPL share holders, is Apple gonna
fall by the wayside?
Apple's
Shares Drop!
Apple's
shares fell as much as 12% as slowing revenue and profit growth
further fanned investor concerns about the company's momentum and
consumer demand for its devices.Wednesday, October 26, 2011
50 Cent Biotech stocks,NASDAQ stocks for a Dollar or LESS
OXGN – OxiGENE is a biopharmaceutical company, develops novel therapeutics to treat cancer and eye diseases. It primarily focuses on the development of vascular disrupting agents (VDAs) that disable and destroy abnormal blood vessels, which provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions.
OXiGENE has several drugs in Phase 1 and Phase II as well as a strategic collaboration agreement with Symphony Capital Partners. Very Attractive, Medium to Long term, keep an eye!
INO - Inovio Pharmaceuticals is developing a DNA vaccines with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Very Attractive, Keep an Eye!
You are missing the Premium Alerts!Sign-up, Get Alerts that MakeMoney!® we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
OXiGENE has several drugs in Phase 1 and Phase II as well as a strategic collaboration agreement with Symphony Capital Partners. Very Attractive, Medium to Long term, keep an eye!
INO - Inovio Pharmaceuticals is developing a DNA vaccines with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Very Attractive, Keep an Eye!
You are missing the Premium Alerts!Sign-up, Get Alerts that MakeMoney!® we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
Subscribe to:
Posts (Atom)